Intentional and non-intentional non-adherence to medication amongst breast cancer patients

Atkins, Louise, Fallowfield, Lesley·2006·European Journal of Cancer
DOI 10.1016/j.ejca.2006.03.004

Cited by (300)

Items 201–300 of 300

  1. Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies
    Marita Lynagh, Tara Clinton‐McHarg, Alix Edna Hall, Rob Sanson‐Fisher, William S. Stevenson, Campbell Tiley, Alessandra Bisquera · 2015 · Experimental Hematology and Oncology
  2. Beliefs and Adherence Associated With Oral and Infusion Chelation Therapies in Jordanian Children and Adolescents With Thalassemia Major: A Comparative Study
    Ghada Mohammad Abu Shosha · 2018 · Journal of Pediatric Hematology/Oncology
  3. Factors Influencing Adherence to Antipsychotic Medications in Women with Delusional Disorder: A Narrative Review
    Alexandre González-Rodríguez, José Antonio Monreal, Mary V. Seeman · 2022 · Current Pharmaceutical Design
  4. Breast cancer and environmental risk factors: an appraisal of the scientific evidence
    Andreas Kortenkamp · 2008 · Breast Cancer Research
  5. Adherencia a la quimioterapia y radioterapia en pacientes oncológicos: una revisión de la literatura
    Ximena Palacios‐Espinosa, Laura P. Vargas-Sterling · 2012 · Psicooncología
  6. RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours
    WN Cooper, RE Dickinson, Ashraf Dallol, Luke B. Hesson, Ivan Bièche, GJ Clark, Eamonn Richard Maher, ER Zabarovsky, Farida Latif · 2008 · Breast Cancer Research
  7. CD44 signalling increases cathepsin K and MT1MMP expression to potentiate breast cancer cell invasion through collagen I
    Ashleigh Hill, Suzanne McFarlane, PG Johnston, DJJ Waugh · 2008 · Breast Cancer Research
  8. Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?
    Àurea Navarro‐Sabaté, Rebeca Font, Josep Alfons Espinàs, J Solà, Fina Martínez‐Soler, Miguel Gil‐Gil, Gemma Viñas, Ariadna Tibau, María Borrell, Miguel Ángel Seguí et al. · 2025 · Cancers
  9. Two functionally distinct epithelial progenitors exist within the luminal cell compartment of the mouse mammary gland
    Julia Stingl, Connie J. Eaves, Christopher J.E. Watson · 2008 · Breast Cancer Research
  10. Quality of Life Issues During Adjuvant Endocrine Therapy
    Lesley J. Fallowfield, Valerie A. Jenkins · 2009 · Cancer treatment and research
  11. Predicting adherence to aromatase inhibitor therapy in patients with breast cancer using protection motivation theory
    Monita Karmakar · 2013 · OhioLink ETD Center (Ohio Library and Information Network)
  12. Health inequalities in breast cancer screening
    James Tollitt, A Jain, Susan Astley · 2008 · Breast Cancer Research
  13. Discussion about switch strategy in the adjuvant hormonal therapy of breast cancer: psychological aspects of physician–patient communication
    Anna Costantini, Angelo Picardi, Marinella Zilli, Fausto Cairoli, Riccardo Torta, Paolo Marchetti, Walter F. Baile, Stefano Iacobelli · 2009 · Annals of Oncology
  14. A novel role for C-terminal binding proteins in the regulation of mitotic fidelity in breast cancer cells
    Lee Bergman, Charles N. Birts, Matthew Darley, Brian G. Gabrielli, Jeremy P. Blaydes · 2008 · Breast Cancer Research
  15. Inhibitor of apoptosis proteins as a therapeutic target in breast cancer
    Fiona M. Foster, Nigel James Bundred, Charles H. Streuli · 2008 · Breast Cancer Research
  16. Psychological adjustment to the onset of rheumatoid arthritis : a longitudinal evaluation of perceptions of, and adherence to, medication
    Lyndsay Dawn Hughes · 2012 · University of Hertfordshire Research Archive (University of Hertfordshire)
  17. Adesão ao tratamento com antineoplásicos orais em pacientes com câncer de mama
    Alinne Ribeiro Teixeira, Bianca Moreira Ruiz, Nathalia Ramalho Cardoso, Verônica de Franco Rennó · 2020 · Revista Brasileira de Ciências Biomédicas
  18. Concordance between reported medication taking behavior and prescription instructions for patients with chronic obstructive pulmonary disease visiting community pharmacies
    Theresa R. Prosser, Suzanne G. Bollmeier · 2022 · Journal of the American Pharmacists Association
  19. Characterizing factors influencing adherence to surgery and chemotherapy amongst women suffering from breast cancer in Mbingo Baptist Hospital Cameroon
    Nsom Gwendoline Nkenu, Marius Nsoh, André Nkondjock, Axler Jean Paul · 2022 · Pan African Medical Journal
  20. Exploring the real-world experience of abemaciclib treatment for HR +, HER2 − metastatic breast cancer—a qualitative analysis of the IMPACTOR study
    Rachel Starkings, Helena Harder, Lesley J. Fallowfield, Valerie M. Shilling · 2025 · Supportive Care in Cancer
  21. Homeopathy service in an NHS hospital breast cancer clinic: outcome study
    SL Hughes, AC Smith, Clare Relton · 2008 · Breast Cancer Research
  22. Inhibition of apoptosis by Notch signalling in breast epithelial cells
    Olivier Meurette, Spyros Stylianou, Giovanna M. Collu, Andrew P. Gilmore, Keith R. Brennan · 2008 · Breast Cancer Research
  23. Lineage commitment in mammary epithelium is regulated by type 2 cytokines and Stat6
    WT Khaled, SE Nicholson, FO Baxter, Naomi S. Sprigg, JP Stingl, ANJ McKenzie, Christopher J.E. Watson · 2008 · Breast Cancer Research
  24. Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer
    C Da Pieve, JN Iley, A Perkins, Sotiris Missailidis · 2008 · Breast Cancer Research
  25. Anti-oestrogen therapy switches off tumour suppressors and proapoptotic genes in breast cancer and reveals a new therapeutic opportunity
    A Stone, Helen Siwan Jones, M.G. Giles, Julia M.W. Gee, Robert I. Nicholson · 2008 · Breast Cancer Research
  26. Patients' and providers' perspectives of a dose administration aid strategy to improve cardiovascular disease prevention in Australian primary healthcare
    Kanika Chaudhri, Hueiming Liu, Anthony Rodgers, Richard P. Day, Emily Atkins, Sonali Rukshana Gnanenthiran · 2025 · BMC Health Services Research
  27. Insulin-like growth factor binding protein 3 modulates epidermal growth factor (EGF)-induced growth of breast epithelial cells by altering EGF receptor internalization
    G.J. Dennison, JMP Holly, Jamie McIntosh, Zoë Winters, Claire M. Perks · 2008 · Breast Cancer Research
  28. Suppression of the NF-κB cofactor Bcl3 inhibits mammary epithelial cell apoptosis and, in breast tumours, correlates with poor prognosis
    A. Wakefield, Luke Piggott, Dawn Croston, Wen G. Jiang, Richard W. E. Clarkson · 2008 · Breast Cancer Research
  29. Activation of TGF-beta signalling in breast cancer metastatic cells
    Silvia Giampieri, Erik A. Sahai · 2008 · Breast Cancer Research
  30. The Effect of Counseling on Patients' Adherence Regarding Anti Hypertensive Therapeutic Regimen
    Manal Salah, A. M. Talaat · 2014
  31. Beliefs of Jordanian Children with Thalassemia toward Using Iron Chelation Therapy
    Ghada Mohammad Abu Shosha · 2016 · Open Journal of Blood Diseases
  32. Long‐term results from a series of patients managed with breast conservation surgery and hypofractionated radiotherapy in Christchurch: What is the recurrence rate and how do we detect recurrences
    Mohamad Firdaus Bin Mohamad Hanib, Bridget Anne Robinson, Chris Miles Frampton, Melissa L James · 2020 · Journal of Medical Imaging and Radiation Oncology
  33. Urinary and serum biomarkers of phytoestrogen exposure are not associated with breast cancer risk in the European Prospective into Cancer Norfolk study
    Heather A Ward, Gaelle Chapelais, GGC Kuhnle, Robert Luben, Kay‐Tee Khaw, Sheila Anne Bingham · 2008 · Breast Cancer Research
  34. How to Optimize Deimplementation of Sentinel Lymph Node Biopsy?
    Ida Dragvoll, Anna Mary Bofin, Håvard Søiland, Monica Jernberg Engstrøm · 2024 · The Breast Journal
  35. Identification of proteins associated with radiotherapy resistance in breast cancer cells: a combined proteomic and microarray screening approach
    L Smith, Omar Qutob, Mandy Watson, Andrew W. Beavis, JKA Jameel, K J Welham, Philip J. Drew, Michael Lind, Lynn Cawkwell · 2008 · Breast Cancer Research
  36. Quantitative proteomics reveals proteins associated with radiotherapy resistance in breast cancer cells
    L Smith, D Potts, Omar Qutob, Mandy Watson, Andrew W. Beavis, Michael Lind, Philip J. Drew, Lynn Cawkwell · 2008 · Breast Cancer Research
  37. Accurate prediction of BRCA1 and BRCA2 heterozygous genotypes using expression profiling of lymphocytes after irradiation-induced DNA damage
    Zsofia Kote‐Jarai, Sarah K. Jugurnauth, L. Matthews, Ian Giddings, Elizabeth Kathryn Bancroft, Richard Dafydd Williams, Mark Girolami, Colin Campbell, Rosalind A. Eeles · 2008 · Breast Cancer Research
  38. Abnormal expression of p53 isoforms can be associated with poor survival in primary breast tumours
    Jean‐Christophe Bourdon · 2008 · Breast Cancer Research
  39. Actions of IGF-I are differentially regulated by fatty acids in normal and breast cancer epithelial cells
    Claire M. Perks, AA Morrison, L Zeng, C Jarrett, Julian P. Hamilton-Shield, Zoë Winters, JMP Holly · 2008 · Breast Cancer Research
  40. Oral anti-cancer chemotherapy: social representations and medical practices
    Véronique Régnier Denois, Jean Baptiste Poirson, Fanny Soum-Pouyalet, Franck Chauvin · 2009
  41. Application of Health Behavior Frameworks in the Design of an Oral Anticancer Medication Adherence App
    2020 · Advances in medical technologies and clinical practice book series
  42. Compliance nella pratica medica e corrente
    Colette Kleinclauss, Alfred Penfornis · 2014 · EMC - AKOS - Trattato di Medicina
  43. Adherence Issues for Oral Antineoplastics
    Susan A. Krikorian, Kanza Shamim · 2012 · American Journal of Lifestyle Medicine
  44. The relationship between psychosocial factors in the patient–oncologist relationship and quality of care: A study of breast cancer patients
    Daniel R. Sikavi, Allyson J. Weseley · 2016 · Journal of Psychosocial Oncology
  45. The drug will not work if the patient fails to take it
    Ida Dragvoll, Anna Mary Bofin, Monica Jernberg Engstrøm · 2022 · Tidsskrift for Den norske legeforening
  46. Avaliação da adesão à terapêutica farmacológica com antineoplásicos orais
    Eliana Marisa Marques Batista · 2012 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  47. Characterization of a cytoskeletal signaling pathway underpinning CD44-initiated, integrin-mediated adhesion of breast cancer cells to bone marrow endothelium
    Suzanne McFarlane, Ashleigh Hill, PG Johnston, DJJ Waugh · 2008 · Breast Cancer Research
  48. D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
    Mustapha Aoubala · 2008 · Breast Cancer Research
  49. Development of a novel validated tool for predicting patient adherence to prescribed medication
    Steven James Watson · 2013 · Lancaster EPrints (Lancaster University)
  50. Primary ductal carcinoma in situmammosphere formation: importance of the epidermal growth factor and Notch receptor signalling pathways
    Gillian Farnie, Katherine Spence, Keith R. Brennan, Nigel James Bundred, Robert B. Clarke · 2008 · Breast Cancer Research
  51. Building better bras for women treated for breast cancer
    Sheridan A. Gho · 2014 · Research Online (University of Wollongong)
  52. Médecine non-conventionnelle et psycho-oncologie : évaluation de l’impact des Médecines Complémentaires et Alternatives (MCA) chez les patients atteints de cancer
    Véronique Suissa · 2017
  53. Non-adherence in Indonesian women with breast cancer and its determinants
    Aulia Iskandarsyah · 2013 · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
  54. Adherence to hormone therapy in a chemoprevention randomised trial
    Lou Atkins, Valerie A. Jenkins, Lesley J. Fallowfield, Anthony Howell · 2008 · Breast Cancer Research
  55. Molecular diversity of human breast cancer: clinical and therapeutic implications
    DJ Slamon · 2008 · Breast Cancer Research
  56. C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target
    Elad Katz, Dana Faratian, JMS Bartlett, Kenneth G. MacLeod, H Pedersen, Alexey A. Larionov, EM Smith, AP Howell, JM Dixon, EE Evans et al. · 2008 · Breast Cancer Research
  57. Loss of oestrogen receptor alpha in long-term antioestrogen-resistant cells: reversal by a c-src inhibitor
    Abdelwahab Bensmail, Iain R. Hutcheson, M.G. Giles, Julia M.W. Gee, Robert I. Nicholson · 2008 · Breast Cancer Research
  58. 'The sooner the better' or 'too much too soon'? A pilot prospective longitudinal study to evaluate quality of life and body image following immediate latissimus dorsi breast reconstruction
    Shelley Potter, HJ Thomson, Lesley J. Fallowfield, Zoë Winters · 2008 · Breast Cancer Research
  59. Mechanisms of apoptosis and cell-cycle arrest in subcutaneous breast tumours treated sequentially with doxorubicin followed by zoledronic acid
    Penelope Dawn Ottewell, Diane V. Lefley, RE Coleman, Ingunn Holen · 2008 · Breast Cancer Research
  60. Cambridge Breast Intensity Modulated Radiotherapy Trial: dosimetry results for 1,139 patients
    Charlotte Elizabeth Coles, J. Wilkinson, CB Wilson, N.G. Burnet, Gordon C. Wishart, N. Twyman, Andrew C.F. Hoole, AM Moody · 2008 · Breast Cancer Research
  61. Chromosomal instability in the pathogenesis and treatment of breast cancer
    Ashok R. Venkitaraman · 2008 · Breast Cancer Research
  62. Cytochrome P450 modulates the therapeutic actions of tamoxifen, as evidenced in novel breast cancer models
    Euan S. Polson, Simone Weidlich, Alasdair Stenhouse, Thomas Friedberg · 2008 · Breast Cancer Research
  63. Pretreatment of breast cancer cells with doxorubicin facilitates the subsequent uptake of zoledronic acid
    Diane V. Lefley, Ingunn Holen, RE Coleman, Penelope Dawn Ottewell · 2008 · Breast Cancer Research
  64. Investigating h-Prune activation of Wnt signalling in breast cancer
    J Freeman, Massimo Zollo, Trevor C. Dale · 2008 · Breast Cancer Research
  65. Identification of genes involved in the formation of lymph node metastasis from human tumour xenograft models of breast cancer
    Lénaïc Paon, SA Eccles · 2008 · Breast Cancer Research
  66. Zinc transporter HKE4 as a new target in antihormone resistance of breast cancer
    Kathryn M. Taylor, Nicola Jordan, Stephen Hiscox, Julia M.W. Gee, RI Nicholson · 2008 · Breast Cancer Research
  67. Identification of components of the ubiquitin system as targets for therapeutic intervention
    Mark K. Saville · 2008 · Breast Cancer Research
  68. Exploring the acceptability of, and preferences for, an ongoing support network for known BRCA1 and BRCA2 mutation carriers
    Louise Hughes, Ceri Phelps, Michael J. Rogers · 2008 · Breast Cancer Research
  69. Proapoptotic protein Bid is regulated by phosphorylation during anoikis and the cell cycle
    Jennefer Lindsay, Andrew P. Gilmore · 2008 · Breast Cancer Research
  70. Lymphovascular invasion in breast cancer: improved methods of detection and clinical significance
    RAA Mohammed, Stewart G. Martin, MS Gill, Andrew R. Green, Emma C. Paish, Ian Ogilvie Ellis · 2008 · Breast Cancer Research
  71. Opioid-taking self-efficacy in Taiwanese Outpatients with cancer pain
    Shu‐Yuan Liang · 2007 · Faculty of Health
  72. Role of CLEVER-1 in breast cancer metastasis
    Aula Ammar, RAA Mohammed, Minja Salmi, Michael Sean Pepper, Emma C. Paish, Ian Ogilvie Ellis, Poulam M. Patel, Stewart G. Martin · 2008 · Breast Cancer Research
  73. A Learning-by-Doing Approach to Medication Management for Adolescent Diabetics
    Steinar Kristoffersen · 2008 · International Journal of Interactive Mobile Technologies (iJIM)
  74. Prospective Study of Outcome in Sporadic versus Hereditary Breast Cancer: pros and cons of running a cohort study
    SM Gerty, PD Simmonds, Lorraine Durcan, Diana Eccles · 2008 · Breast Cancer Research
  75. Surviving breast cancer: can women expect to 'get back to normal'?
    Penelope Hopwood · 2008 · Breast Cancer Research
  76. Prostate Cancer; Metabolic Risk Factors, Drug Utilisation, Adverse Drug Reactions
    Birgitta Grundmark · 2013 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  77. The QUEST study: a multicentre randomised trial to assess the impact of the type and timing of breast reconstruction on quality of life following mastectomy
    Shelley Potter, Zoë Winters · 2008 · Breast Cancer Research
  78. Adesão e persistência à terapia endócrina para o câncer de mama, fatores preditores e resultados relacionados
    Cláudia Brito · 2011 · Americanae (AECID Library)
  79. erapie dans le cancer du sein et l'observance des traitements : quel est le r^ ole du pharmacien ocinal ?
    Claire Frodeau · 2013
  80. Intentional and unintentional medication nonadherence
    Jamie Suat-Ling Ng · 2016
  81. Correlation between the Stage of Change in Dance Exercise Behavior for Physical Strength, Risk Factors of Metabolic Syndrome, and Lifestyles in College Students
    Seung Won Yang, kim-jeyoung · 2014 · Official Journal of the Koeran Society of Dance Science
  82. Adherencia a la quimioterapia y radioterapia en pacientes oncológicos : una revisión de la literatura
    Laura P. Vargas-Sterling · 2011 · instname:Universidad del Rosario
  83. Survivorship Issues
    Carmel Sheppard · 2010 · Wiley eBooks
  84. Adesão e sintomas urinários em mulheres com câncer de mama em tratamento com hormonioterapia oral
    Rebeca Stahlschmidt · 2018
  85. DEMATEL Analysis of Medication Non-Adherence Behavior of Patients
    Saibal Kumar Saha, Anindita Adhikary, Ajeya K. Jha, Vijay Kumar Mehta · 2022 · International Journal of Reliable and Quality E-Healthcare
  86. Evaluation of the Acceptability and Utility of a Decision Aid for the Treatment of Adult Depression
    Jenny Rogojanski · 2021
  87. Evaluation of the Acceptability and Utility of a Decision Aid for the Treatment of Adult Depression
    Jenny Rogojanski · 2021
  88. Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes
    Scott Wilkie, Gianfranco Picco, J Foster, David Marc Davies, Sylvain Julien, Leslie Cooper, Spogmai Arif, S. J. Mather, Joyce Taylor‐Papadimitriou, Joy Burchell et al. · 2008 · Breast Cancer Research
  89. Adjuvant antihormonal treatment in breast cancer. Understanding how poor adherence affects survival
    Ida Dragvoll, Anna Mary Bofin, Håvard Søiland, Øyvind Olav Salvesen, Monica Jernberg Engstrøm · 2023 · Research Square
  90. Effectiveness of a pharmacist-led expert system for medication adherence and blood pressure control of adults with hypertension in the Philippines: a randomized controlled trial
    Margarita M. Gutierrez · 2021
  91. Verabreichung von parenteralen und oralen Tumortherapien
    Anja Kröner, Christina Züger · 2024 · Springer eBooks
  92. Changes in Technical Equipment and Patient Perspectives Navigating Towards Enhanced Digitalization in Breast Cancer Across Pre-COVID-19 and Early COVID-19 Eras
    Florian Schindler, Rachel Wuerstlein, Timo Schinköthe, Anna Marie Debes, Caroline Paysen, Nadia Harbeck, Tanja Kristina Eggersmann · 2024 · Clinical Breast Cancer
  93. Group-Based Trajectory Modeling to Identify Patterns and Predictors of Adherence to Oral Endocrine Therapies in Underserved Population of Greater Houston Area
    Yashvi Patel, Hasan Alsaedi, Zahra Majd, Issra Altaie, Sama Rahimi, Bilqees Fatima, Onyebuchi Ononogbu, Susan Abughosh, Meghana V. Trivedi · 2025 · Patient Preference and Adherence
  94. The effect of medical drug reminder mobile application on treatment compliance in women with breast cancer under adjuvant hormone treatment
    Özge Budaycı, Sevgi Özkan · 2025 · Pamukkale Medical Journal
  95. Additional file 1 of An accurate method of measuring shoulder sling compliance: a validation study
    Anshum Sood, Ashley Klein, Samir Kaveeshwar, Derek L. Jones, Grant T. Duvall, James Paul Hovis, Tristan B. Weir, Blessing Enobun, S. Ashfaq Hasan, Henn, R. Frank et al. · 2021 · Figshare
  96. Additional file 2 of An accurate method of measuring shoulder sling compliance: a validation study
    Anshum Sood, Ashley Klein, Samir Kaveeshwar, Derek L. Jones, Grant T. Duvall, James Paul Hovis, Tristan B. Weir, Blessing Enobun, S. Ashfaq Hasan, Henn, R. Frank et al. · 2021 · Figshare
  97. Additional file 2 of Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy
    Sophie M C Green, David French, Graham, Christopher D., Louise Hall, Rousseau, Nikki, Robbie Foy, Clark, Jane, Catherine Parbutt, Erin Raine, Benjamin Gardner et al. · 2022 · Figshare
  98. Additional file 1 of Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy
    Sophie M C Green, David French, Graham, Christopher D., Louise Hall, Rousseau, Nikki, Robbie Foy, Clark, Jane, Catherine Parbutt, Erin Raine, Benjamin Gardner et al. · 2022 · Figshare
  99. Additional file 4 of Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy
    Sophie M C Green, David French, Graham, Christopher D., Louise Hall, Rousseau, Nikki, Robbie Foy, Clark, Jane, Catherine Parbutt, Erin Raine, Benjamin Gardner et al. · 2022 · Figshare
  100. Thérapies ciblées chez les femmes atteintes de cancer du sein métastatique : diffusion, impact sur la prise en charge, poids des représentations sociales et adhésion thérapeutique
    Élise Martin · 2017